908 Devices Inc.
NASDAQ:MASSMedical - Devices
+$0.22 today
- Market cap
- $395.86M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
Volume 0.25M
Average 0.27M
MASS Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
908 Devices Inc.NASDAQ: MASS
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin narrows to -89.3%
Net margin was -89.3% in Q1 FY2026, down 459.6 pp from a year earlier. On a trailing-twelve-month basis it was -62.1%, down 30.8 pp year over year. Over 3 fiscal years it widened by 6.4 pp.
Context
- Net margin widened in 1 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 5 analysts of -8.8% for the fiscal year ending Dec 2026, up from -65.2% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -89.3%-114.0 pp QoQ
- Last fiscal yearDec 2025
- -65.2%+55.9 pp YoY
- LTMMar 2026
- -62.1%-30.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -459.6 pp | +64.1 pp | +523.7 pp |
| 1 year | +55.9 pp | +56.4 pp | +0.5 pp |
| 3 years | +6.4 pp | +49.9 pp | +43.5 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -65.2%
- Year-over-year change
- +55.9pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -65.2% | +55.9pp |
| FY2024 | 2024-12-31 | -121.1% | -48.6pp |
| FY2023 | 2023-12-31 | -72.5% | -0.8pp |
| FY2022 | 2022-12-31 | -71.6% | -19.1pp |
| FY2021 | 2021-12-31 | -52.5% | — |
Net Margin vs competitors
How MASS compares with its peers on the latest reported figures
- MASS's LTM Mar 2026 net margin of -62.1% is the lowest of the 3 companies compared; the peer median is 19.5%.
- Its year-over-year change of -30.8 pp is the lowest of 3, against a peer median of +1.4 pp.
- Over three fiscal years its change of +6.4 pp compares with a peer median of +0.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jul 2026 | 19.5% | +1.6 pp | +0.4 pp | |
| LTM Jun 2026 | 19.5% | +1.2 pp | +0.6 pp | |
| LTM Mar 2026 | -62.1% | -30.8 pp | +6.4 pp | |
| Peer median (excluding MASS) | 19.5% | +1.4 pp | +0.5 pp | |
Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 42.21M | 46.85M | 50.23M | 59.63M | 56.2M |
| Cost of Revenue | 18.97M | 20.83M | 24.91M | 29.71M | 29.4M |
| Gross Profit | 23.23M | 26.02M | 25.32M | 29.93M | 26.8M |
| Gross Margin | 55.0% | 55.5% | 50.4% | 50.2% | 47.7% |
| Research & Development | 13.07M | 17.53M | 21.9M | 25.5M | 13.8M |
| Selling, General & Admin | 32.24M | 43.88M | 0 | 0 | 37.18M |
| Operating Expenses | 45.3M | 61.41M | 68.08M | 106.64M | 50.98M |
| Depreciation & Amortization | 925K | 1.61M | 2.38M | 4.68M | 4.47M |
| EBITDA | (20.76M) | (31.82M) | (40.27M) | (43.88M) | (28.88M) |
| EBITDA Margin | -49.2% | -67.9% | -80.2% | -73.6% | -51.4% |
| Operating Income | (22.07M) | (35.38M) | (42.76M) | (76.72M) | (24.18M) |
| Operating Margin | -52.3% | -75.5% | -85.1% | -128.7% | -43.0% |
| Interest Income | 548K | 2.03M | 6.48M | 4.49M | 4.14M |
| Interest Expense | 486K | 129K | 201K | 0 | 0 |
| Other Income / Expenses | (100K) | 1.82M | 6.15M | 4.23M | (9.16M) |
| Income Before Tax | (22.17M) | (33.56M) | (36.61M) | (72.49M) | (33.34M) |
| Pre-Tax Margin | -52.5% | -71.6% | -72.9% | -121.6% | -59.3% |
| Income Tax Expense | 0 | 0 | (211K) | (282K) | (66K) |
| Net Income | (22.17M) | (33.56M) | (36.4M) | (72.21M) | (36.64M) |
| Net Margin | -52.5% | -71.6% | -72.5% | -121.1% | -65.2% |
| EPS (Basic) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| EPS (Diluted) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| Weighted Avg Shares | 27.96M | 31.49M | 32.21M | 34.08M | 36.22M |
| Weighted Avg Shares (Diluted) | 27.96M | 31.49M | 32.24M | 34.08M | 38.92M |
908 Devices Inc.
NASDAQ:MASS
Intrinsic Alpha fair value
Locked
Current Price
$9.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.